Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
27 hedge funds and large institutions have $3.12M invested in Vyant Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
17% more funds holding
Funds holding: 23 → 27 (+4)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
41% less capital invested
Capital invested by funds: $5.27M → $3.12M (-$2.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$96.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.9K |
| 3 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$22.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$20.6K |
| 5 |
Millennium Management
New York
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWMP
Taylor Wealth Management Partners
Boston,
Massachusetts
|
-$70.1K |
| 2 |
Renaissance Technologies
New York
|
-$26.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.29K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CA
26
Cornerstone Advisory
Hunt Valley,
Maryland
| – | +$31 | +3 | New |
|
27
Bank of America
Charlotte,
North Carolina
| – | +$102 | +10 | New |
|
VYNT Hedge Fund Activity: Q4 2021 in Review
27 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q4 2021, worth a combined $3.12M — down 41% from $5.27M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VYNT positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $96.5K. The largest seller was Taylor Wealth Management Partners, cutting an estimated $70.1K.
- 27 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q4 2021, up from 23 in Q3 2021.
- Funds reported $3.12M of Vyant Bio, Inc. Common Stock stock for Q4 2021, down 41% quarter-over-quarter.
- 6 funds opened new Vyant Bio, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +4 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q4 2021 was Virtu Financial, an estimated $96.5K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q4 2021 was Taylor Wealth Management Partners, an estimated $70.1K sold.
Based on aggregated 13F filings for Q4 2021.